Solana Company

NASDAQ:HSDT

Medical - Devices

Healthcare
$1.63 +0.63%

+$0.01 today

Market cap
$95.17M
Beta
1.03
P/E (TTM)
-0.9
EPS (TTM)
-$1.78
52W Low $1.19High $25.50

Volume 0.23M

Average 0.38M

HSDT Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Solana CompanyNASDAQ: HSDT

Stock-Based Compensation · Q1 FY2026 · quarter ended Mar 2026

Stock-based compensation dips below year-ago levels

Q1 FY2026 stock-based compensation of $90K fell 85.5% year over year, behind the +217.8% change in trailing-twelve-month stock-based compensation. Sequentially, it fell 98.8% from the prior quarter.

Context

  • Stock-based compensation amounted to 153.7% of revenue in FY2025, down 331.3 pp from a year earlier.
  • Stock-based compensation increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -85.5% toward the trailing-twelve-month pace of +217.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$90K-98.8% QoQ
Last fiscal yearDec 2025
$9.25M+266.8% YoY
LTMMar 2026
$8.72M+217.8% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-85.5%——
1 year+266.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

USD · from the cash flow

Latest · FY2025
9.25M USD
Year-over-year change
+266.8%

Stock-Based Compensation vs competitors

How HSDT compares with its peers on the latest reported figures

  • HSDT's LTM Mar 2026 stock-based compensation of $8.72M is the 5th largest of the 11 companies compared; the peer median is $6.68M.
  • Its year-over-year change of +217.8% is the highest of 11, against a peer median of +4.6%.
  • Stock-based compensation amounts to 90.9% of revenue for HSDT, versus a peer median of 10.2%.
HSDT Competitors Peer median
Stock-Based Compensation for HSDT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OMOutset Medical, Inc.LTM Mar 2026$16.09M -33.3%-16.9%13.7%
TLSITriSalus Life Sciences, Inc.LTM Mar 2026$9.98M +67.1%+191.7%22.2%
QTRXQuanterix CorporationLTM Mar 2026$9.79M +79.2%+10.3%6.8%
CATXPerspective Therapeutics, Inc.LTM Mar 2026$9.42M +38.0%+88.2%1524.4%
HSDTSolana CompanyLTM Mar 2026$8.72M +217.8%—90.9%
INGNInogen, Inc.LTM Mar 2026$7.82M +9.7%-13.3%2.2%
PROFProfound Medical Corp.LTM Mar 2026$5.55M +98.0%+9.0%29.4%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$4.49M -0.5%+4.5%3.2%
NNOXNano-X Imaging Ltd.LTM Dec 2025$4.19M -42.3%-39.2%32.2%
ELMDElectromed, Inc.LTM Mar 2026$2.61M -8.5%+46.3%3.6%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$2.38M -344.3%—5.4%
Peer median (excluding HSDT) $6.68M+4.6%+9.0%10.2%

Competitors are the stored peer set for HSDT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(18.13M)(14.07M)(8.85M)(11.74M)(40.89M)
Depreciation & Amortization374K306K162K60K680K
Deferred Income Tax00000
Stock-Based Compensation001.63M2.52M9.25M
Change in Working Capital127K(1.31M)(311K)(8K)230K
Accounts Receivables1K(103K)(291K)(5K)0
Inventory(87K)(111K)137K(607K)(85K)
Accounts Payables369K(418K)(103K)344K1.02M
Other Working Capital(156K)(674K)(54K)260K(702K)
Other Non-Cash Items4.24M762K(3.05M)(1.87M)14.22M
Operating Cash Flow(13.39M)(14.31M)(10.42M)(11.04M)(16.51M)
Capital Expenditures(54K)(17K)(29K)(5K)(44.78M)
Acquisitions (Net)06K000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities0000(426.53M)
Investing Cash Flow(56K)(11K)(29K)(5K)(426.53M)
Debt Repayment0000(680K)
Common Stock Issued21.13M17.87M1.08M6.95M467.03M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0003.99M(17.11M)
Financing Cash Flow21.13M17.87M1.08M6.95M449.24M
Effect of Forex Changes(8K)(4K)1K(2K)1K
Net Change in Cash7.67M3.54M(9.37M)(4.09M)6.19M
Free Cash Flow(13.44M)(14.33M)(10.45M)(11.05M)(61.29M)

Solana Company

NASDAQ:HSDT

Intrinsic Alpha fair value

Locked

Current Price

$1.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.